Fed. Circ. Remands Denial Of Antibody Patent

Law360, New York (February 25, 2010, 3:48 PM EST) -- A federal appeals court has remanded the Board of Patent Appeals and Interferences' denial of a patent application describing methods of combining antibody fragments, finding that the board misunderstood the prior art cited to support the decision.

The U.S. Court of Appeals for the Federal Circuit on Wednesday acknowledged that the U.S. Patent and Trademark Office board may be right in denying a patent application by inventors Andrew Paul Chapman and David John King as obvious, but directed it to reconsider the issue with a more...
To view the full article, register now.